Skip to content
Synlife logo — Artificial cells as novel therapeutics.

Synlife

Artificial cells as novel therapeutics.

Founded 2017 United States Cambridge, United States 3 employees Seed Total: $700.00K Biotechnology, Health Care +1

General Information

Company Name Synlife
Founded Year 2017
Location United States Cambridge, United States
Employees 3
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Synlife. To contact Synlife, visit synlifebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Synlife compare?

A PDF of Synlife and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Synlife soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Synlife

Synlife is a biotechnology startup founded in 2017, with a focus on developing artificial cells for the treatment of metabolic diseases. Their slogan, "Artificial cells as novel therapeutics," encapsulates their innovative approach. In July 2018, they secured a $700.00K investment in a Seed Round, signaling early support for their groundbreaking work. With a focus on biotechnology, health care, and the pharmaceutical industry, Synlife is positioned to make a significant impact in the healthcare sector. While the company's headquarters information is not provided, the recent investment underscores the potential of their synthetic cell-based therapeutics.

Business keywords: Synthetic Biology, Therapeutics, Metabolic Diseases, Diagnostic Platforms, Biochemical Engineering, Genetic Engineering, Synthetic Cells, DNA Program, Protein Engineering, Cell-Free Systems

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $700.00K -
27 Jul 2018

Synlife Alternatives & Competitors

View All Alternatives
Synlife vs

We are a synthetic biology company developing a platform to industrialize and scale the microbiome.

Seed
22 employees
AI, Biotechnology
Synlife vs
Synlogic
Synlogic United States

Designed for Life

IPO
20 employees
Biotechnology, Health Care
Synlife vs
Satellite Bio
Satellite Bio United States

Tackling some of humankind’s most elusive diseases with Tissue Therapeutics, a new category of regen...

Series A
24 employees
Biotechnology, Pharmaceutical

FAQ About Synlife

Artificial cells as novel therapeutics.
Synlife was founded in 2017.
Synlife is headquartered in Cambridge, United States.
Synlife operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Synthetic Biology, Therapeutics, Metabolic Diseases and Diagnostic Platforms.
Synlife has approximately 3 employees.
Synlife has completed 1 funding round, raising a total of $700.00K. The latest funding stage is Seed.
Top alternatives and competitors to Synlife include Persephone Biosciences, Synlogic, Satellite Bio, Abintus Bio, Inc., Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synlife and Persephone Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Synlife, https://www.bouncewatch.com/company/synlife, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout